TD-1607 SAD Study in Healthy Subjects

Summary

TD-1607, administered intravenously as single doses, will be investigated in healthy subjects to assess its tolerability, safety, and pharmacokinetics.

Timeline

Start

2013-04

Primary completion

2013-08

Completion

2013-10

Drugs

Indications